Aduhelm by Biogen Source: Biogen The FDA’s approval of Biogen‘s Alzheimer’s drug Aduhelm was a landmark moment in the life of Dr. Paul Aisen. The director of the Alzheimer’s Therapeutic Research Institute at USC has spent the past three decades focused on treating the neurodegenerative disease, and in recent years helped shepherd this particular drug… Read More »
Article content Toronto’s chief public-health official has won the right to intervene in a court dispute over vaccinating a divorced couple’s children, a rare step Dr. Eileen de Villa says was necessary to combat dangerous misinformation about vaccines. The city’s medical officer of health (MOH) now has lawyers taking part in an appeal slated for… Read More »
AbbVie’s strength has long been tied to the performance of megablockbuster Humira, which is facing an existential threat as U.S. copycats creep closer. Despite a “more aggressive” than expected biosimilar challenge abroad, AbbVie believes its defense strategy—and lessons learned—will help it weather the storm. In an earnings call with analysts Friday, AbbVie CEO Rick Gonzalez touted the drugmaker’s… Read More »
Do you want to lose weight? If you do you are not alone. An estimated 160 million Americans, including males and females , are either obese or overweight . America has a severe obesity epidemic that has serious long term health implications. The cause of the obesity epidemic is the American lifestyle. This means… Read More »